Evidence map›Paper›PMID 35655889›Full record

ArticleChemical science2022

Sulfonium cations as versatile strongly π-acidic ligands.

Ruiping Li, Nitsan Barel, Vasudevan Subramaniyan, Orit Cohen, Françoise Tibika, Yuri Tulchinsky

Abstract read
In one paragraph

Article in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Cationic Sulfonium-Based Tripodal Ligand and Its Rh(I) Complexes.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ruiping LiInstitute of Chemistry, The Hebrew University of Jerusalem Jerusalem 9190401 Israel yuri.tulchinsky@mail.huji.ac.il.ORCID https://orcid.org/0000-0003-2063-6359
Nitsan BarelInstitute of Chemistry, The Hebrew University of Jerusalem Jerusalem 9190401 Israel yuri.tulchinsky@mail.huji.ac.il.ORCID https://orcid.org/0000-0001-7983-3280
Vasudevan SubramaniyanInstitute of Chemistry, The Hebrew University of Jerusalem Jerusalem 9190401 Israel yuri.tulchinsky@mail.huji.ac.il.ORCID https://orcid.org/0000-0001-8130-6789
Orit CohenInstitute of Chemistry, The Hebrew University of Jerusalem Jerusalem 9190401 Israel yuri.tulchinsky@mail.huji.ac.il.ORCID https://orcid.org/0000-0003-2342-9902
Françoise TibikaInstitute of Chemistry, The Hebrew University of Jerusalem Jerusalem 9190401 Israel yuri.tulchinsky@mail.huji.ac.il.
Yuri TulchinskyInstitute of Chemistry, The Hebrew University of Jerusalem Jerusalem 9190401 Israel yuri.tulchinsky@mail.huji.ac.il.ORCID https://orcid.org/0000-0002-8423-0836

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

More than a century old, sulfonium cations are still intriguing species in the landscape of organic chemistry. On one hand they have found broad applications in organic synthesis and materials science, but on the other hand, while isoelectronic to the ubiquitous tertiary phosphine ligands, their own coordination chemistry has been neglected for the last three decades. Here we report the synthesis and full characterization of the first Rh(i) and Pt(ii) complexes of sulfonium. Moreover, for the first time, coordination of an aromatic sulfonium has been established. A thorough computational analysis of the exceptionally short S-Rh bonds obtained attests to the strongly π-accepting nature of sulfonium cations and places them among the best π-acceptor ligands available today. Our calculations also show that embedding within a pincer framework enhances their π-acidity even further. Therefore, in addition to the stability and modularity that these frameworks offer, our pincer complexes might open the way for sulfonium cations to become powerful tools in π-acid catalysis.

Identifiers

PMID35655889
PMCPMC9067576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.